DexCom, Inc. (DXCM)
69.20
-0.50
(-0.72%)
USD |
NASDAQ |
Jan 15, 16:00
69.18
-0.02
(-0.03%)
After-Hours: 20:00
DexCom SG&A Expense (TTM): 1.297B for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| BioLife Solutions, Inc. | 56.57M |
| Abbott Laboratories | 12.11B |
| Krystal Biotech, Inc. | 136.75M |
| Boston Scientific Corp. | 6.666B |
| Tandem Diabetes Care, Inc. | 437.73M |